Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening

Cellular Physiology and Biochemistry

Volumn 25, Issue 4-5, 2010, Pages 459-466

  Liang, Huamin ^a,c   Matzkies, Matthias ^a   Schunkert, Heribert ^b   Tang, Ming ^c   Bonnemeier, Hendrik ^b   Hescheler, Jürgen ^a   Reppel, Michael ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antiarrhythmic drugs; Cardiomyocytes; Drug screening; Human embryonic stem cells; QT screening; Repolarization

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; QUINIDINE; SOTALOL; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG SCREENING; ELECTRIC POTENTIAL; EMBRYO; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HEART REPOLARIZATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; SPECIES DIFFERENCE;

MURINAE;

EID: 77949923815     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000303051     Document Type: Article

References (37)

1. Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, Antzelevitch C, Escande D, Franz M, Malik M, Moss A, Shah R: The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J 2000;21:1216-1231.
2. Haddad PM, Anderson IM: Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drug 2002;62:1649-1671.
3. Di Diego JM, Belardinelli L, Antzelevitch C: Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation. Circulation 2003;108:1027-1033.
4. Joshi A, Dimino T, Vohra Y, Cui C, Yan GX: Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: the role of experimental models. J Electrocardio 2004;37 Suppl:7-14.
5. Hoshiyama K, Hara M, Yasui K, Mitamura H, Ohsuzu F, Kodama I, Ogawa S: Altered action potential dynamics in electrically remodeled canine atria: evidence for altered intracellular Ca2+ handling. Circ J 2006;70:1488-1496.
6. Laszlo R, Winkler C, Wöhrl S, Laszlo S, Eick C, Schreieck J, Bosch RF: Influence of verapamil on tachycardia-induced alterations of PP1 and PP2A in rabbit atrium. Exp Clin Cardio 2007;12:175-178.
7. Sato T, Takizawa T, Saito T, Kobayashi S, Hara Y, Nakaya H: Amiodarone inhibits sarcolemmal but not mitochondrial KATP channels in Guinea pig ventricular cells. J Pharmacol Exp The 2003;307:955-960.
8. Reppel M, Pillekamp F, Lu ZJ, Halbach M, Brockmeier K, Fleischmann BK, Hescheler J: Microelectrode arrays: a new tool to measure embryonic heart activity. J Electrocardiol 2004;37 Suppl:104-109.
9. Reppel M, Igelmund P, Egert U, Juchelka F, Hescheler J, Drobinskaya I: Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 2007;19:213-224.
10. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L£° Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Inves 2001;108:407-414.
11. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ: Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003;93:32-39.
12. Reppel M, Pillekamp F, Brockmeier K, Matzkies M, Bekcioglu A, Lipke T, Nguemo F, Bonnemeier H, Hescheler J: The electrocardiogram of human embryonic stem cell-derived cardiomyocytes. J Electrocardiol 2005;38:166-170.
13. Abi-Gerges N, Ji GJ, Lu ZJ, Fischmeister R, Hescheler J, Fleischmann BK: Functional expression and regulation of the hyperpolarization activated non-selective cation current in embryonic stem cell-derived cardiomyocytes. Journal of Physiolog 2000;523:377-389.
14. Passier R, Oostwaard DW, Snapper J, Kloots J, Hassink RJ, Kuijk E, Roelen B, de la Riviere AB, Mummery C: Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cell 2005;23:772-780.
15. Stett A, Egert U, Guenther E, Hofmann F, Meyer T, Nisch W, Haemmerle H: Biological application of microelectrode arrays in drug discovery and basic research. Anal Bioanal Chem 2003;377:486-495.
16. Egert U, Knott T, Schwarz C, Nawrot M, Brandt A, Rotter S, Diesmann M: MEA-Tools: an open source toolbox for the analysis of multi-electrode data with MATLAB. J Neurosci Method 2002; 117:33-42.
17. Valdes R, Jr., Jortani SA, Gheorghiade M: Standards of laboratory practice: cardiac drug monitoring. National Academy of Clinical Biochemistry. Clin Chem 1998;44:1096-1109.
18. Roden DM, Balser JR, George AL Jr, Anderson ME: Cardiac ion channels. Annu Rev Physiol 2002;64:431-475.
19. Ducroq J, Printemps R, Guilbot S, Gardette J, Salvetat C, Le Grand M: Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies. J Pharmacol Toxicol Methods 2007;56:159-170.
20. Tytgat J, Vereecke J, Carmeliet E: Differential effects of verapamil and flunarizine on cardiac L-type and T-type Ca channels. Naunyn Schmiedebergs Arch Pharmacol 1988; 337:690-692.
21. Zahradnik I, Minarovic I, Zahradnikova A: Inhibition of the cardiac L-type calcium channel current by antidepressant drugs. J Pharmacol Exp Ther 2008;324:977-984.
22. Bova S, Cargnelli G, D'Amato E, Forti S, Yang Q, Trevisi L, Debetto P, Cima L, Luciani S, Padrini R: Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil. Br J Pharmaco 1997:19-24.
23. Hondeghem L, Katzung BG: Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction. Circulation 1980;61:1217-1224
24. Doupnik CA, Davidson N, Lester HA: The inward rectifier potassium channel family. Curr Opin Neurobiol 1995;5:268-277.
25. Kurokawa J: Compartmentalized regulations of ion channels in the heart. Biol Pharm Bull 2007;30:2231-2237.
26. Knollmann BC, Roden DM: A genetic framework for improving arrhythmia therapy. Nature 2008;21451:929-936.
27. Vaughan Williams EM: The experimental basis for the choice of an anti-arrhythmic drug. Adv Cardiol 1970;4:275-289.
28. Yap YG, Camm AJ: Drug induced QT prolongation and torsades de pointes. Heart 2003;89:1363-1372.
29. Sanguinetti MC, Jurkiewicz NK: Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:195-215.
30. Ficker E, Jarolimek W, Kiehn J, Baumann A, Brown AM: Molecular determinants of dofetilide block of HERG K+ channels. Circ Res 1998;82:386-395.
31. Wettwer E, Grundke M, Ravens U: Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes. Cardiovasc Res 1992;26:1145-1152.
32. Feng J, Wang Z, Li GR, Nattel S: Effects of class III antiarrhythmic drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther 1997;81:384-392.
33. Sah R, Ramirez RJ, Oudit GY, Gidrewicz D, Trivieri MG, Zobel C, Backx PH: Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (I(to)). J Physiol 2003;1 546:5-18.
34. Thomas D, Karle CA, Kiehn J: The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications. Curr Pharm Des 2006;12:2271-2283.
35. Michael G, Xiao L, Qi XY, Dobrev D, Nattel S: Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis. Cardiovasc Res 2009;81:491-499.
36. Dobrev D, Ravens U: Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 2003;98:137-148.
37. Moreno J, Warren M, Jalife J. Ionic currents and ventricular fibrillation dynamics. Rev Esp Cardiol 2004;57:69-79.